Escitalopram prevents relapse of obsessive-compulsive disorder
Authors:
- Naomi A. FinebergNFNaomi A. Fineberg
- Brigitte TonnoirBTBrigitte Tonnoir
- Ole LemmingOLOle Lemming
- Dan J. SteinDSDan J. Stein
- 1 May 2007
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 17 (6-7) , 430-439
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Discontinuation symptoms in depression and anxiety disordersInternational Journal of Neuropsychopharmacology, 2005
- A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorderClinical Psychology Review, 2004
- Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With ParoxetineThe Journal of Clinical Psychiatry, 2003
- Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria Empirically Supported in Randomized Clinical Trials?Journal of Child and Adolescent Psychopharmacology, 2003
- A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry, 2003
- A Randomized Controlled Trial of Cognitive Therapy versus Intensive Behavior Therapy in Obsessive Compulsive DisorderPsychotherapy and Psychosomatics, 2001
- Evidence-based pharmacotherapy of obsessive–compulsive disorderInternational Journal of Neuropsychopharmacology, 1999
- A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorderInternational Clinical Psychopharmacology, 1995
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989
- Obsessive-Compulsive DisorderArchives of General Psychiatry, 1983